Pediatrix Medical Group, Inc. (MD)
NYSE
Price as at 30 Sept 2026, 21:08 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Pediatrix Medical Group, Inc. trades at $25.73. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.
About Pediatrix Medical Group, Inc.
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
Super investor ownership
8 of the funds we track reported a position in their latest SEC 13F filing. Largest first:
- D. E. Shaw, D. E. Shaw & Co., Inc.$40.86M · 0.0% of book
- Renaissance Technologies, RENAISSANCE TECHNOLOGIES LLC$32.61M · 0.0% of book
- Cliff Asness, AQR CAPITAL MANAGEMENT LLC$11.53M · 0.0% of book
- Joel Greenblatt, Gotham Asset Management, LLC$2.10M · 0.0% of book
- Israel Englander, MILLENNIUM MANAGEMENT LLC$1.40M · 0.0% of book
A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.
Politician trades in MD
Trades in MD disclosed by members of Congress and executive-branch officials, latest first:
- Donna Shalala · HouseSell · $50,001 - $100,000 · traded 15 Oct 2019 · disclosed 27 Apr 2020
- Greg Gianforte · HouseSell · $50,001 - $100,000 · traded 26 Oct 2018 · disclosed 29 Oct 2018
A disclosure reports a value band, not an amount, and is due up to 45 days after the trade; some arrive later. Every filer we track, each with their own page, is on the Congress trading tracker.
Common questions
Which funds own MD?
8 of the institutions we track reported a position in MD in their most recent SEC 13F filing. A 13F is filed up to 45 days after quarter end, so it tells you what a fund held then, not what it holds now.
Where does SteadyShares get its MD data?
Fundamentals for MD come from company filings and exchange data, as listed on NYSE; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 30 Sept 2026, 21:08 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for MD, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.